封面
市場調查報告書
商品編碼
2067543

美國超音波切片檢查市場規模、佔有率和趨勢分析報告:按產品、手術、方式、CPT 代碼、部位和細分市場預測(2026-2033 年)

U.S. Endobronchial Ultrasound Biopsy Market Size, Share & Trends Analysis Report By Product, By Procedure, By Modality, By CPT Codes, By Site, And Segment Forecasts, 2026 - 2033

出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10個工作天內

價格

美國支氣管內超音波切片檢查市場概覽

據估計,2025 年美國支氣管內超音波切片檢查市場價值為 3,250 萬美元,預計到 2033 年將達到 4,570 萬美元,2026 年至 2033 年的複合年成長率為 4.4%。

該市場也可分為治療方面,預計到 2025 年市場規模將達到 8.61 億美元,並預計從 2026 年到 2033 年將以 6.5% 的複合年成長率成長。

推動市場成長的關鍵因素包括肺癌和呼吸系統疾病發病率的上升、技術的快速進步以及美國支氣管內超音波切片檢查(EBUS)市場競爭的加劇。此外,肺癌篩檢計畫的擴展、先進支氣管鏡技術的普及促進了EBUS的應用,以及有利的保險報銷方案和臨床指南也是推動市場成長的因素。

美國各州肺癌篩檢計畫的擴展是推動支氣管內超音波(EBUS)普及的主要動力。這是因為低劑量CT(LDCT)的廣泛應用提高了早期肺結節和縱膈異常的檢出率,有助於明確的診斷和分期。主導和社區主導的各項舉措,著重於改善醫療服務可及性、消除醫療資源分配不均以及整合人工智慧等先進技術,正在擴大高危險群和醫療資源匱乏人群的篩檢覆蓋範圍。這導致接受診斷的患者人數顯著增加,進而推動了對EBUS等微創手術的需求。例如:

  • 2026年3月,美國肺臟協會宣布了一項全州範圍的計劃,為伊利諾伊州高風險居民提供免費的低劑量CT肺癌篩檢,直至5月,旨在促進早期發現。該計劃旨在透過提供導航支援、交通和經濟援助,幫助人們克服就醫障礙,從而解決篩檢方面的差異,尤其是在黑人和西班牙裔社區。
  • 2025年9月,俄亥俄州立大學綜合癌症中心「詹姆斯」啟動了一輛行動肺癌篩檢車,旨在擴大俄亥俄州的早期檢測和預防工作,尤其是在運作的社區。這輛篩檢車在全州巡迴,為高風險族群提供低劑量CT篩檢,旨在改善篩檢服務可近性,克服地域障礙,實現早期診斷,並最終改善治療效果。
  • 2025年4月,加州健康肺臟舉措(Healthy Lungs California)透過加州大學肺癌聯盟與阿斯特捷利康公司開展為期五年的夥伴關係,進一步擴大了該計畫的覆蓋範圍,旨在提高肺癌的早期檢出率並降低死亡率。該計畫著重解決不平等問題和環境風險因素,例如空氣污染和野火暴露,同時致力於改善服務不足社區的醫療服務可近性,進行社區篩檢活動,並引入人工智慧檢測等創新技術。

此外,美國醫院中先進支氣管鏡技術(包括電磁導航支氣管鏡和離子輔助機器人切片檢查)的日益普及,直接加速了從經胸針吸活體組織切片(TTNA)、傳統支氣管鏡和外科切片檢查等傳統診斷方法向新型診斷方法的轉變。

這些技術利用3D影像、導航系統和機器人控制,能夠精準定位到位於肺部邊緣、難以觸及的小型肺結節,顯著提高診斷準確率,同時降低併發症和創傷性。隨著這些技術在肺結節評估中日益普及,它們擴大與支氣管內超音波(EBUS)聯合使用,用於全面的診斷和分期,直接推動了EBUS檢查數量的成長。

例如,2026年3月,史密斯堡仁慈醫院引進了機器人輔助支氣管鏡技術,旨在更精準、微創地診斷肺結節,並提高肺部疾病的早期檢出率。該系統利用先進的3D CT影像和機器人導航技術,能夠到達微小或難以觸及的病灶,在同一手術過程中完成切片檢查,從而減少侵入性手術或住院的需要。

目錄

第1章:調查方法和範圍

第2章執行摘要

第3章 市場:變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 每次手術平均使用的針頭數量(按類型分類)
  • 商業環境分析

第4章:美國支氣管內超音波切片檢查(產品端)市場:設備、估算與趨勢分析

  • 按設備類型分類的市場佔有率和波動分析(2025 年和 2033 年)
  • 按設備類型分類的市場規模、預測和趨勢分析(2020-2033 年)
  • EBUS 示波器/EBUS 系統
    • 凸面 EBUS 內視鏡 (CP-EBUS)
    • 徑向探頭類型 EBUS 範圍 (RP-EBUS)
  • 超音波處理器和影像處理系統

第5章:美國支氣管內超音波切片檢查(產品端)市場:耗材、估算與趨勢分析

  • 按消費品類別分類的市場佔有率和波動分析(2025 年和 2033 年)
  • 按消費品類別分類的市場規模、預測和趨勢分析(2020-2033 年)
  • EBUS-TBNA 針頭和專用切片檢查耗材
    • 2021-2033 年 EBUS-TBNA 針和專用切片檢查耗材的市場銷售(千件)。
  • EBUS相關支氣管鏡檢查耗材及配件
    • 2021-2033 年 EBUS 相關支氣管鏡耗材及配件的市場規模(千單位)。
    • 切片檢查鉗
    • 細胞學刷
  • 低溫探針
    • 2021年至2033年低溫探針市場銷售量(千台)
    • 導鞘套
    • 配件

第6章:美國支氣管內超音波切片檢查(手術方面)市場:依手術類型分類的估算與趨勢分析

  • 按治療類型分類的市場佔有率和波動分析(2025 年和 2033 年)
  • 按治療類型分類的市場規模、預測和趨勢分析(2020-2033 年)
  • 孤立性支氣管內超音波淋巴結切片術
    • 孤立性 EBUS 淋巴結活體組織切片手術市場:2021 年至 2033 年進行的手術數量(1,000)。
  • 合併治療
    • 綜合治療市場,2021年至2033年手術量(千例)

第7章:美國支氣管內超音波切片檢查(手術方面)市場:按方式分類的估算和趨勢分析

  • 按模式分類的儀表板
  • 按治療方式分類的市場佔有率和波動分析(2025 年和 2033 年)
  • 經胸針吸活體組織切片切片檢查(TTNA)
    • 經胸針切片檢查(TTNA)市場:市場規模(千例)2021-2033年
  • 常規支氣管鏡檢查
    • 2021 年至 2033 年傳統支氣管鏡市場規模(千台)。
  • 手術切片檢查
    • 2021 年至 2033 年切片檢查市場規模(千台)。
  • 電磁導航支氣管鏡檢查(ENB)
    • 電磁導航支氣管鏡(ENB)市場:市場規模(千台)2021-2033年
  • 機器人輔助支氣管鏡檢查
    • 2021-2033 年機器人輔助支氣管鏡市場規模(千台)

第8章:美國支氣管內超音波切片檢查(手術方面)市場:按CPT代碼分類的估算與趨勢分析

  • 按 CPT 代碼分類的市場佔有率和波動分析(2025 年和 2033 年)
  • 按 CPT 代碼分類的市場規模、預測和趨勢分析(2020-2033 年)
  • 31652
    • 2021 年至 2033 年,31,652 個市場,實施數量(1,000 台)。
  • 31653
    • 2021 年至 2033 年,31,653 個市場,實施數量(1,000 台)。
  • 31654
    • 2021 年至 2033 年,31,654 個市場,實施數量(1,000 台)。

第9章:美國支氣管內超音波切片檢查(手術方面)市場:按CPT代碼分類的估算與趨勢分析

  • 按 CPT 代碼分類的市場佔有率和波動分析(2025 年和 2033 年)
  • 按 CPT 代碼分類的市場規模、預測和趨勢分析(2020-2033 年)
  • 31652
    • 2021 年至 2033 年,31,652 個市場,實施數量(1,000 台)。
  • 31653
    • 2021-2033 年市場規模(每 1,000 單位)為 31,653 個市場單位。
  • 31654
    • 2021 年至 2033 年,31,654 個市場,實施數量(1,000 台)。

第 10 章:美國支氣管內超音波切片檢查市場(手術方面):按機構分類的估計和趨勢分析。

  • 按設施分類的市場佔有率和波動分析(2025 年和 2033 年)
  • 按設施類型分類的市場規模、預測和趨勢分析(2020-2033 年)
  • 大學醫學中心
    • 2021-2033年學術醫療中心市場規模(數千家)
  • 當地醫院
    • 區域醫院市場規模(2021年至2033年,單位:千家)
  • 門診手術中心(ASC)
    • 2021-2033 年門診手術中心 (ASC) 市場規模(千家)。

第 11 章:美國支氣管內超音波(介入)市場:依手術次數和設施數量估算和趨勢分析。

  • 按治療項目和設施數量分類的市場佔有率及波動分析(2025 年和 2033 年)
  • 按治療項目和設施數量分類的市場規模、預測和趨勢分析(2020-2033 年)
  • 獨立式 EBUS
    • 大學醫院
    • 當地醫院
    • 門診手術中心(ASC)
  • EBUS合併治療
    • 大學醫院
    • 當地醫院
    • 門診手術中心(ASC)

第12章:美國超音波切片檢查市場(手術方面):按手術數量和開展該手術的機構數量進行的估算和趨勢分析

  • 按治療項目和設施數量分類的市場佔有率及波動分析(2025 年和 2033 年)
  • 按治療項目和設施數量分類的市場規模、預測和趨勢分析(2020-2033 年)
  • 獨立式 EBUS
    • 大學醫院
    • 當地醫院
    • 門診手術中心(ASC)
  • EBUS合併治療
    • 大學醫院
    • 當地醫院
    • 門診手術中心(ASC)

第13章 競爭格局

  • 參與企業概況
  • 企業市場分析(2025)
  • 公司分類
  • 2025年企業市場占有率分析(%) - 整體產品市場
  • EBUS 內企業市場占有率分析,2025 年(%)
  • 策略規劃
  • 公司簡介列表
    • 賓得醫療(HOYA集團旗下部門)
    • Boston Scientific Corporation
    • 奧林巴斯美國公司(奧林巴斯株式會社的子公司)
    • FUJIFILM Holdings Corporation
    • Cook Group
    • Medi-Globe Technologies GmbH
    • ACE Medical Devices Pvt. Ltd.
    • Praxis Medical
    • CONMED
Product Code: GVR-4-68040-906-5

U.S. Endobronchial Ultrasound Biopsy Market Summary

The U.S. endobronchial ultrasound biopsy market size was estimated at USD 32.5 million in 2025 and is projected to reach USD 45.7 million by 2033, growing at a CAGR of 4.4% from 2026 to 2033. The market is also categorized into a procedure side which was estimated at USD 861.0 million in 2025 and is projected to grow at a CAGR of 6.5% from 2026 to 2033.

Key factors contributing to the market growth include rising incidence of lung cancer and respiratory disorders, rapid technological evolution and increasing market competition in the U.S. endobronchial ultrasound biopsy (EBUS) market. In addition, expansion of lung cancer screening programs, shift toward advanced bronchoscopy modalities driving EBUS adoption, favorable reimbursement and clinical guidelines.

The expansion of lung cancer screening programs across U.S. states is a key driver of EBUS adoption, as the increasing use of low-dose CT (LDCT) is leading to higher detection of early-stage lung nodules and mediastinal abnormalities that require confirmatory diagnosis and staging. State-led and community-based initiatives focused on improving access, reducing disparities, and integrating advanced technologies such as AI are expanding screening coverage among high-risk and underserved populations. This is significantly increasing patient volumes entering diagnostic pathways, thereby driving demand for minimally invasive procedures such as EBUS. For instance:

  • In March 2026, the American Lung Association announced a statewide initiative offering free low-dose CT lung cancer screenings to at-risk Illinois residents through May to improve early detection. The program aims to reduce screening disparities, particularly among Black and Hispanic populations, by providing navigation support, transportation, and financial assistance to overcome barriers to care.
  • In September 2025, the Ohio State University Comprehensive Cancer Center James launched a mobile lung cancer screening unit to expand early detection and prevention efforts across Ohio, particularly targeting underserved communities. The unit travels statewide to provide low-dose CT screenings for high-risk populations, aiming to improve access, reduce geographic barriers, and enable earlier diagnosis, thereby improving treatment outcomes.
  • In April 2025, The Healthy Lungs California initiative was expanded through a five-year partnership between the University of California Lung Cancer Consortium and AstraZeneca to improve early lung cancer screening rates and reduce mortality. The program focuses on increasing access in underserved communities, launching local screening efforts, and integrating innovations such as AI-assisted detection while addressing disparities and environmental risk factors like pollution and wildfire exposure

Moreover, the growing adoption of advanced bronchoscopy modalities, including electromagnetic navigation bronchoscopy and Ion-based robotic-assisted bronchoscopy, across U.S. hospitals is directly driving the transition away from conventional diagnostic approaches such as transthoracic needle aspiration (TTNA), traditional bronchoscopy, and surgical biopsy.

These technologies enable precise navigation to small, peripheral, and hard-to-reach lung nodules using 3D imaging, navigation systems, and robotic control, significantly improving diagnostic yield while reducing complications and invasiveness. As these modalities become integral to lung nodule evaluation, they are increasingly used in combination with EBUS for comprehensive diagnosis and staging, thereby directly contributing to higher EBUS procedural volumes.

For instance, in March 2026, Mercy Hospital Fort Smith introduced robotic-assisted bronchoscopy technology to enable more precise, minimally invasive diagnosis of lung nodules and improve early detection of lung disease. The system uses advanced 3D CT mapping and robotic navigation to access small or hard-to-reach lesions, allowing same-procedure biopsy while reducing the need for invasive surgeries and hospital stays.

U.S. Endobronchial Ultrasound Biopsy Market Report Segmentation

This report forecasts revenue growth at U.S. levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. Endobronchial Ultrasound Biopsy market report based on the product side market (Equipment and Consumables), the procedure side market (Procedures, modality, CPT codes, end use).

  • Product Side Market
  • Equipment Outlook (Annual Equipment Sales Volume (Absolute Number), Revenue, USD Million 2021 - 2033)
    • EBUS Scopes / EBUS Systems
    • Linear EBUS (CP-EBUS)
    • Radial Probe EBUS (RP-EBUS)
    • Ultrasound Processors and Imaging Systems
  • Consumables Outlook (Annual Equipment Sales Volume (Absolute Number), Revenue, USD Million 2021 - 2033)
    • EBUS-TBNA Needles
    • EBUS-Related Bronchoscopic Procedure Consumables and Accessories
    • Biopsy Forceps
    • Cytology Brushes
    • Cryoprobes
    • Guide Sheaths
    • Accessories
  • Procedure Side Market Outlook
  • Procedure Outlook (Procedure Volume, in '000 Procedures, Revenue, USD Million 2021 - 2033)
    • Standalone EBUS Lymph Node Biopsy Procedures
    • Combined Procedures
  • CPT Codes Outlook (Procedure Volume, in '000, Revenue, USD Million 2021 - 2033)
    • 31652
    • 31653
    • 31654
  • Site Outlook (Procedure Volume, in '000, Revenue, USD Million 2021 - 2033)
    • Academic Medical Centers
    • Community Hospitals
    • Ambulatory Surgical Centers (ASCs)
  • Modality Outlook (Procedure Volume, in '000, Revenue, USD Million 2021 - 2033)
    • Transthoracic Needle Aspiration (TTNA)
    • Traditional Bronchoscopy
    • Surgical Biopsy
    • Electromagnetic Navigation Bronchoscopy
    • Robotic-Assisted Bronchoscopy
  • Procedure Vs Site Outlook (Procedure Volume, in '000 Procedures, 2021 - 2033)
    • Standalone EBUS Lymph Node Biopsy Procedures
    • Academic Medical Centers
    • Community Hospitals
    • Ambulatory Surgical Centers (ASCs)
    • Combined Procedures
    • Academic Medical Centers
    • Community Hospitals
    • Ambulatory Surgical Centers (ASCs)

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
  • 1.3. Segment Definition - Product Side Market
    • 1.3.1. Equipment
    • 1.3.2. Consumables
  • 1.4. Segment Definition - Procedure-Side Market
    • 1.4.1. Procedure
    • 1.4.2. Modality
    • 1.4.3. CPT Code
    • 1.4.4. Site
  • 1.5. Estimates and Forecast Timeline
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Data Visualization
  • 1.9. Objectives
  • 1.10. Objective - 1
  • 1.11. Objective - 2
  • 1.12. Objective - 3
  • 1.13. Model Details
    • 1.13.1. Research Methodology - For Overall Number of EBUS Procedures Performed In U.S.
    • 1.13.2. Research Methodology for The - Convex / Linear EBUS (CP-EBUS) Procedure Volume Estimation - U.S.
    • 1.13.3. Research Methodology for The - Radial Probe EBUS (RP-EBUS) Procedure Volume Model - U.S.
    • 1.13.4. Research Methodology - For Equipment Installed Base
    • 1.13.5. Research Methodology for End-Use Cross-Segmentation
    • 1.13.6. Research Methodology for Modality-Segmentation
    • 1.13.7. Commodity Flow Analysis
  • 1.14. List of Secondary Sources
  • 1.15. List of Abbreviation

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising Incidence of Lung Cancer and Respiratory Disorders
      • 3.2.1.2. Rapid Technological Evolution and Increasing Market Competition in the U.S. Endobronchial Ultrasound Biopsy (EBUS) Market
        • 3.2.1.2.1. Innovation In EBUS Bronchoscopes Enhancing Diagnostic Precision and Procedural Efficiency
        • 3.2.1.2.2. Continuous Technological Advancements in EBUS-TBNA Devices Improving Sampling Accuracy and Diagnostic Yield
      • 3.2.1.3. Expansion Of Lung Cancer Screening Programs Across U.S. States
      • 3.2.1.4. Shift Toward Advanced Bronchoscopy Modalities Driving EBUS Adoption
      • 3.2.1.5. Favorable Reimbursement and Clinical Guideline
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. The high cost of EBUS systems and associated procedures
      • 3.2.2.2. Requirement for highly skilled professionals
    • 3.2.3. Industry Opportunity Analysis
      • 3.2.3.1. Integration Of AI and Digital Technologies Enhancing EBUS Precision and Workflow Efficiency
      • 3.2.3.2. Expanding Clinical Applications of EBUS Beyond Lung Cancer
  • 3.3. Average Number of Needles Used Per Procedure, By Type
    • 3.3.1. Standalone EBUS Lymph Node Biopsy Procedures
    • 3.3.2. Combined EBUS Lymph Node Biopsy Procedures
  • 3.4. Business Environment Analysis
    • 3.4.1. Porter's Five Forces Analysis
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTLE Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal Landscape

Chapter 4. U.S. Endobronchial Ultrasound Biopsy (Product Side) Market: Equipment Estimates & Trend Analysis

  • 4.1. Equipment Segment Dashboard
  • 4.2. Equipment Market Share Movement Analysis, 2025 & 2033
  • 4.3. Market Size & Forecasts and Trend Analysis, by equipment, 2020 to 2033 (USD Million)
  • 4.4. EBUS Scopes / EBUS Systems
    • 4.4.1. EBUS Scopes / EBUS Systems Market, 2021 - 2033 (USD Million)
    • 4.4.2. EBUS Scopes / EBUS Systems Market, 2020 - 2033 (Annual Equipment Sales Volume (Absolute Number))
    • 4.4.3. Convex EBUS Scopes (CP-EBUS)
      • 4.4.3.1. Convex EBUS Scopes (CP-EBUS) Market, 2021 - 2033 (USD Million)
      • 4.4.3.2. Convex EBUS Scopes (CP-EBUS) Market, 2020 - 2033 (Annual Equipment Sales Volume (Absolute Number))
    • 4.4.4. Radial Probe EBUS Scopes (RP-EBUS)
      • 4.4.4.1. Radial Probe EBUS Scopes (RP-EBUS) Market, 2021 - 2033 (USD Million)
      • 4.4.4.2. Radial Probe EBUS Scopes (RP-EBUS) Market, 2020 - 2033 (Annual Equipment Sales Volume (Absolute Number))
  • 4.5. Ultrasound Processors and Imaging Systems
    • 4.5.1. Ultrasound Processors and Imaging Systems Market, 2021 - 2033 (USD Million)
    • 4.5.2. Ultrasound Processors and Imaging Systems Market, 2020 - 2033 (Annual Equipment Sales Volume (Absolute Number))

Chapter 5. U.S. Endobronchial Ultrasound Biopsy (Product Side) Market: Consumables Estimates & Trend Analysis

  • 5.1. Consumables Segment Dashboard
  • 5.2. Consumables Market Share Movement Analysis, 2025 & 2033
  • 5.3. Market Size & Forecasts and Trend Analysis, by Consumables, 2020 to 2033 (USD Million)
  • 5.4. EBUS-TBNA Needles
    • 5.4.1. EBUS-TBNA Needles Market, 2021 - 2033 (USD Million)
    • 5.4.2. EBUS-TBNA Needles & Dedicated Biopsy Consumables Market, Volume 2021 - 2033 (000')
  • 5.5. EBUS-Related Bronchoscopic Procedure Consumables and Accessories
    • 5.5.1. EBUS-Related Bronchoscopic Procedure Consumables and Accessories Market, 2021 - 2033 (USD Million)
    • 5.5.2. EBUS-Related Bronchoscopic Procedure Consumables and Accessories Market, Volume 2021 - 2033 (000')
    • 5.5.3. Biopsy Forceps
      • 5.5.3.1. Biopsy Forceps Market, 2021 - 2033 (USD Million)
      • 5.5.3.2. Biopsy Forceps Market, Volume 2021 - 2033 (000')
    • 5.5.4. Cytology Brushes
      • 5.5.4.1. Cytology Brushes Market, 2021 - 2033 (USD Million)
      • 5.5.4.2. Cytology Brushes Market, Volume 2021 - 2033 (000')
  • 5.6. Cryoprobes
    • 5.6.1. Cryoprobes Market, 2021 - 2033 (USD Million)
    • 5.6.2. Cryoprobes Market, Volume 2021 - 2033 (000')
    • 5.6.3. Guide Sheaths
      • 5.6.3.1. Guide Sheaths Market, 2021 - 2033 (USD Million)
      • 5.6.3.2. Guide Sheaths Market, Volume 2021 - 2033 (000')
    • 5.6.4. Accessories
      • 5.6.4.1. Accessories Market, 2021 - 2033 (USD Million)
      • 5.6.4.2. Accessories Market, Volume 2021 - 2033 (000')

Chapter 6. U.S. Endobronchial Ultrasound Biopsy (Procedure Side) Market: Procedure Estimates & Trend Analysis

  • 6.1. Procedure Segment Dashboard
  • 6.2. Procedure Market Share Movement Analysis, 2025 & 2033
  • 6.3. Market Size & Forecasts and Trend Analysis, by Procedure, 2020 to 2033 (USD Million)
  • 6.4. Standalone EBUS Lymph Node Biopsy Procedures
    • 6.4.1. Standalone EBUS Lymph Node Biopsy Procedures Market, 2020 - 2033 (USD Million)
    • 6.4.2. Standalone EBUS Lymph Node Biopsy Procedures Market, Volume 2021 - 2033 (000')
  • 6.5. Combined Procedures
    • 6.5.1. Combined Procedures Market, 2020 - 2033 (USD Million)
    • 6.5.2. Combined Procedures Market, Volume 2021 - 2033 (000')

Chapter 7. U.S. Endobronchial Ultrasound Biopsy (Procedure Side) Market: Modality Estimates & Trend Analysis

  • 7.1. Modality Dashboard
  • 7.2. Modality Market Share Movement Analysis, 2025 & 2033
  • 7.3. Transthoracic Needle Aspiration (TTNA)
    • 7.3.1. Transthoracic Needle Aspiration Market, 2021 - 2033 (USD Million)
    • 7.3.2. Transthoracic Needle Aspiration Market, Volume 2021 - 2033 (000')
  • 7.4. Traditional Bronchoscopy
    • 7.4.1. Traditional Bronchoscopy Market, 2021 - 2033 (USD Million)
    • 7.4.2. Traditional Bronchoscopy Market, Volume 2021 - 2033 (000')
  • 7.5. Surgical Biopsy
    • 7.5.1. Surgical Biopsy Market, 2021 - 2033 (USD Million)
    • 7.5.2. Surgical Biopsy Market, Volume 2021 - 2033 (000')
  • 7.6. Electromagnetic Navigation Bronchoscopy (ENB)
    • 7.6.1. Electromagnetic Navigation Bronchoscopy (ENB) Market, 2021 - 2033 (USD Million)
    • 7.6.2. Electromagnetic Navigation Bronchoscopy (ENB) Market, Volume 2021 - 2033 (000')
  • 7.7. Robotic-Assisted Bronchoscopy
    • 7.7.1. Robotic-Assisted Bronchoscopy Market, 2021 - 2033 (USD Million)
    • 7.7.2. Robotic-Assisted Bronchoscopy Market, Volume 2021 - 2033 (000')

Chapter 8. U.S. Endobronchial Ultrasound Biopsy (Procedure Side) Market: CPT Code Estimates & Trend Analysis

  • 8.1. CPT Code Segment Dashboard
  • 8.2. CPT Code Market Share Movement Analysis, 2025 & 2033
  • 8.3. Market Size & Forecasts and Trend Analysis, by CPT Code, 2020 to 2033 (USD Million)
  • 8.4. 31652
    • 8.4.1. 31652 Market, 2020 - 2033 (USD Million)
    • 8.4.2. 31652 Market, Volume 2021 - 2033 (000')
  • 8.5. 31653
    • 8.5.1. 31653 Market, 2020 - 2033 (USD Million)
    • 8.5.2. 31653 Market, Volume 2021 - 2033 (000')
  • 8.6. 31654
    • 8.6.1. 31654 Market, 2020 - 2033 (USD Million)
    • 8.6.2. 31654 Market, Volume 2021 - 2033 (000')

Chapter 9. U.S. Endobronchial Ultrasound Biopsy (Procedure Side) Market: CPT Code Estimates & Trend Analysis

  • 9.1. CPT Code Segment Dashboard
  • 9.2. CPT Code Market Share Movement Analysis, 2025 & 2033
  • 9.3. Market Size & Forecasts and Trend Analysis, by CPT Code, 2020 to 2033 (USD Million)
  • 9.4. 31652
    • 9.4.1. 31652 Market, 2020 - 2033 (USD Million)
    • 9.4.2. 31652 Market, Volume 2021 - 2033 (000')
  • 9.5. 31653
    • 9.5.1. 31653 Market, 2020 - 2033 (USD Million)
    • 9.5.2. 31653 Market, Volume 2021 - 2033 (000')
  • 9.6. 31654
    • 9.6.1. 31654 Market, 2020 - 2033 (USD Million)
    • 9.6.2. 31654 Market, Volume 2021 - 2033 (000')

Chapter 10. U.S. Endobronchial Ultrasound Biopsy (Procedure Side) Market: Site Estimates & Trend Analysis

  • 10.1. Site Segment Dashboard
  • 10.2. Site Market Share Movement Analysis, 2025 & 2033
  • 10.3. Market Size & Forecasts and Trend Analysis, by Site, 2020 to 2033 (USD Million)
  • 10.4. Academic Medical Centers
    • 10.4.1. Academic Medical Centers Market, 2021 - 2033 (USD Million)
    • 10.4.2. Academic Medical Centers Market, Volume 2021 - 2033 (000')
  • 10.5. Community Hospitals
    • 10.5.1. Community Hospitals Market, 2021 - 2033 (USD Million)
    • 10.5.2. Community Hospitals Market, Volume 2021 - 2033 (000')
  • 10.6. Ambulatory Surgical Centers (ASCs)
    • 10.6.1. Ambulatory Surgical Centers (ASCs) Market, 2021 - 2033 (USD Million)
    • 10.6.2. Ambulatory Surgical Centers (ASCs) Market, Volume 2021 - 2033 (000')

Chapter 11. U.S Endobronchial Ultrasound (Procedure Side) Market: Procedures Vs Site Estimates & Trend Analysis

  • 11.1. Procedures Vs Site Segment Dashboard
  • 11.2. Procedures Vs Site Market Share Movement Analysis, 2025 & 2033
  • 11.3. Market Size & Forecasts and Trend Analysis, by Procedures Vs Site, 2020 to 2033 (USD Million)
  • 11.4. Standalone EBUS
    • 11.4.1. Academic Medical Centers
      • 11.4.1.1. Academic Medical Centers Market, 2021 - 2033 (USD Million)
    • 11.4.2. Community Hospitals
      • 11.4.2.1. Community Hospitals Market, 2021 - 2033 (USD Million)
    • 11.4.3. Ambulatory Surgical Centers (ASCs)
      • 11.4.3.1. Ambulatory Surgical Centers (ASCs) Market, 2021 - 2033 (USD Million)
  • 11.5. Combined EBUS Procedures
    • 11.5.1. Academic Medical Centers
      • 11.5.1.1. Academic Medical Centers Market, 2021 - 2033 (USD Million)
    • 11.5.2. Community Hospitals
      • 11.5.2.1. Community Hospitals Market, 2021 - 2033 (USD Million)
    • 11.5.3. Ambulatory Surgical Centers (ASCs)
      • 11.5.3.1. Ambulatory Surgical Centers (ASCs) Market, 2021 - 2033 (USD Million)

Chapter 12. U.S. Endobronchial Ultrasound Biopsy (Procedure Side) Market: Procedures Vs Site Estimates & Trend Analysis

  • 12.1. Procedures Vs Site Segment Dashboard
  • 12.2. Procedures Vs Site Market Share Movement Analysis, 2025 & 2033
  • 12.3. Market Size & Forecasts and Trend Analysis, by Procedures Vs Site, 2020 to 2033 (USD Million)
  • 12.4. Standalone EBUS
    • 12.4.1. Academic Medical Centers
      • 12.4.1.1. Academic Medical Centers Market, 2021 - 2033 (USD Million)
    • 12.4.2. Community Hospitals
      • 12.4.2.1. Community Hospitals Market, 2021 - 2033 (USD Million)
    • 12.4.3. Ambulatory Surgical Centers (ASCs)
      • 12.4.3.1. Ambulatory Surgical Centers (ASCs) Market, 2021 - 2033 (USD Million)
  • 12.5. Combined EBUS Procedures
    • 12.5.1. Academic Medical Centers
      • 12.5.1.1. Academic Medical Centers Market, 2021 - 2033 (USD Million)
    • 12.5.2. Community Hospitals
      • 12.5.2.1. Community Hospitals Market, 2021 - 2033 (USD Million)
    • 12.5.3. Ambulatory Surgical Centers (ASCs)
      • 12.5.3.1. Ambulatory Surgical Centers (ASCs) Market, 2021 - 2033 (USD Million)

Chapter 13. Competitive Landscape

  • 13.1. Participant Overview
  • 13.2. Company Market Position Analysis, (2025)
  • 13.3. Company Categorization
  • 13.4. Company Market Share Analysis, 2025 (%) - Overall Product Side Market
  • 13.5. Company Market Share Analysis for EBUS Scopes, 2025 (%)
  • 13.6. Strategy Mapping
  • 13.7. Company Profiles/Listing
    • 13.7.1. PENTAX Medical (a division of HOYA Group)
      • 13.7.1.1. Overview
      • 13.7.1.2. Financial performance
      • 13.7.1.3. Product Benchmarking
      • 13.7.1.4. Strategic initiatives
    • 13.7.2. Boston Scientific Corporation
      • 13.7.2.1. Overview
      • 13.7.2.2. Financial performance
      • 13.7.2.3. Product Benchmarking
      • 13.7.2.4. Strategic initiatives
    • 13.7.3. Olympus America (Subsidiary of Olympus Corporation)
      • 13.7.3.1. Overview
      • 13.7.3.2. Financial performance
      • 13.7.3.3. Product Benchmarking
      • 13.7.3.4. Strategic initiatives
    • 13.7.4. FUJIFILM Holdings Corporation
      • 13.7.4.1. Overview
      • 13.7.4.2. Financial performance
      • 13.7.4.3. Product Benchmarking
      • 13.7.4.4. Strategic initiatives
    • 13.7.5. Cook Group
      • 13.7.5.1. Overview
      • 13.7.5.2. Financial performance
      • 13.7.5.3. Product Benchmarking
      • 13.7.5.4. Strategic initiatives
    • 13.7.6. Medi-Globe Technologies GmbH
      • 13.7.6.1. Overview
      • 13.7.6.2. Financial performance
      • 13.7.6.3. Product Benchmarking
      • 13.7.6.4. Strategic initiatives
    • 13.7.7. ACE Medical Devices Pvt. Ltd.
      • 13.7.7.1. Overview
      • 13.7.7.2. Financial performance
      • 13.7.7.3. Product Benchmarking
      • 13.7.7.4. Strategic initiatives
    • 13.7.8. Praxis Medical
      • 13.7.8.1. Overview
      • 13.7.8.2. Financial performance
      • 13.7.8.3. Product Benchmarking
      • 13.7.8.4. Strategic initiatives
    • 13.7.9. CONMED
      • 13.7.9.1. Overview
      • 13.7.9.2. Financial performance
      • 13.7.9.3. Product Benchmarking
      • 13.7.9.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 List of secondary sources
  • Table 3 U.S. Endobronchial Ultrasound Biopsy (EBUS) Market, By Equipment, 2021 - 2033 (USD Million)
  • Table 4 U.S. Endobronchial Ultrasound Biopsy (EBUS) Market, By Equipment, 2021 - 2033 (Annual Equipment Sales Volume (Absolute Number))
  • Table 5 U.S. Endobronchial Ultrasound Biopsy (EBUS) Market, By Consumables, 2021 - 2033 (USD Million)
  • Table 6 U.S. Endobronchial Ultrasound Biopsy (EBUS) Market, By Product, 2021 - 2033 (USD Million)
  • Table 7 U.S. Endobronchial Ultrasound Biopsy (EBUS) Market, By Procedure, 2021 - 2033 (USD Million)
  • Table 8 U.S. Endobronchial Ultrasound Biopsy (EBUS) Market, By Procedure, Volume 2021 - 2033 (000')
  • Table 9 U.S. Endobronchial Ultrasound Biopsy (EBUS) Market, By Modality, 2021 - 2033 (USD Million)
  • Table 10 U.S. Endobronchial Ultrasound Biopsy (EBUS) Market, By Modality, Volume 2021 - 2033 (000')
  • Table 11 U.S. Endobronchial Ultrasound Biopsy (EBUS) Market, By CPT Codes, 2021 - 2033 (USD Million)
  • Table 12 U.S. Endobronchial Ultrasound Biopsy (EBUS) Market, By CPT Codes, Volume 2021 - 2033 (000')
  • Table 13 U.S. Endobronchial Ultrasound Biopsy (EBUS) Market, By Site, 2021 - 2033 (USD Million)
  • Table 14 U.S. Endobronchial Ultrasound Biopsy (EBUS) Market, By Site, Volume 2021 - 2033 (000')
  • Table 15 U.S. Endobronchial Ultrasound Biopsy (EBUS) Market, By Prodecure Vs Site, 2021 - 2033 (USD Million)
  • Table 16 U.S. Endobronchial Ultrasound Biopsy (EBUS) Market, By Prodecure Vs Site, Volume 2021 - 2033 (000')
  • Table 17 U.S. Average Selling Price Of Needles, 2025 (USD)
  • Table 18 Estimated Company Market Share Analysis, 2025 (%) - Overall Product Side Market
  • Table 19 Estimated Company Market Share Analysis For EBU.S. Scopes, 2025 (%)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Endobronchial ultrasound market: Market outlook
  • Fig. 5 Endobronchial ultrasound market: Segment outlook
  • Fig. 6 Endobronchial ultrasound market: Competitive landscape outlook
  • Fig. 7 Market Dynamics
  • Fig. 8 Market Driver Relevance Analysis
  • Fig. 9 Incidence Of Lung Cancer
  • Fig. 10 Market Restraint Relevance Analysis
  • Fig. 11 Porter's Five Forces Analysis
  • Fig. 12 PESTEL Analysis
  • Fig. 13 U.S. Endobronchial Ultrasound Biopsy (EBUS) Equipment Market: Segment Dashboard
  • Fig. 14 U.S. Endobronchial Ultrasound Biopsy (EBUS) Market By Equipment: Market Share Analysis, 2025 & 2033
  • Fig. 15 EBUS Scopes/ EBUS Systems Market 2021 - 2033 (USD Million)
  • Fig. 16 EBUS Scopes/ EBUS Systems Market, 2021 - 2033 (Annual Equipment Sales Volume (Absolute Number))
  • Fig. 17 Convex EBUS Scopes (CP-EBUS) Market 2021 - 2033 (USD Million)
  • Fig. 18 Convex EBUS Scopes (CP-EBUS) Market, 2021 - 2033 (Annual Equipment Sales Volume (Absolute Number))
  • Fig. 19 Radial Probe EBUS Scopes (RP-EBUS) Market 2021 - 2033 (USD Million)
  • Fig. 20 Radial Probe EBUS Scopes (RP-EBUS) Market, 2021 - 2033 (Annual Equipment Sales Volume (Absolute Number))
  • Fig. 21 Ultrasound Processors And Imaging Systems Market 2021 - 2033 (USD Million)
  • Fig. 22 Ultrasound Processors And Imaging Systems Market, 2021 - 2033 (Annual Equipment Sales Volume (Absolute Number))
  • Fig. 23 US Endobronchial Ultrasound Biopsy (EBUS) Consumables Market: Segment Dashboard
  • Fig. 24 US Endobronchial Ultrasound Biopsy (EBUS) Market By Consumables: Market Share Analysis, 2025 & 2033
  • Fig. 25 EBUS-TBNA Needles & Dedicated Biopsy Consumables Market 2021 - 2033 (USD Million)
  • Fig. 26 EBUS-TBNA Needles & Dedicated Biopsy Consumables Market, Volume 2021 - 2033 (000')
  • Fig. 27 EBUS-Related Bronchoscopic Procedure Consumables And Accessories Market 2021 - 2033 (USD Million)
  • Fig. 28 EBUS-Related Bronchoscopic Procedure Consumables And Accessories Market, Volume 2021 - 2033 (000')
  • Fig. 29 Biopsy Forceps Market 2021 - 2033 (USD Million)
  • Fig. 30 Biopsy Forceps Market, Volume 2021 - 2033 (000')
  • Fig. 31 Cytology Brushes Market 2021 - 2033 (USD Million)
  • Fig. 32 Cytology Brushes Market, Volume 2021 - 2033 (000')
  • Fig. 33 Cryoprobes Market 2021 - 2033 (USD Million)
  • Fig. 34 Cryoprobes Market, Volume 2021 - 2033 (000')
  • Fig. 35 Guide Sheaths Market 2021 - 2033 (USD Million)
  • Fig. 36 Guide Sheaths Market, Volume 2021 - 2033 (000')
  • Fig. 37 Accessories Market 2021 - 2033 (USD Million)
  • Fig. 38 Accessories Market, Volume 2021 - 2033 (000')
  • Fig. 39 US Endobronchial Ultrasound Biopsy (EBUS) Market: Procedure Segment Dashboard
  • Fig. 40 US Endobronchial Ultrasound Biopsy (EBUS) Market By Procedure: Market Share Analysis, 2025 & 2033
  • Fig. 41 Standalone EBUS Lymph Node Biopsy Procedures Market, 2021-2033 (USD Million)
  • Fig. 42 Standalone EBUS Lymph Node Biopsy Procedures Market, Volume 2021 - 2033 (000')
  • Fig. 43 Combined Procedures Market 2021-2033 (USD Million)
  • Fig. 44 Combined Procedures Market, Volume 2021 - 2033 (000')
  • Fig. 45 US Endobronchial Ultrasound Biopsy (EBUS) Modality Market: Segment Dashboard
  • Fig. 46 US Endobronchial Ultrasound Biopsy (EBUS) Market By Modality: Market Share Analysis, 2025 & 2033
  • Fig. 47 Transthoracic Needle Aspiration Market, 2021 - 2033 (USD Million)
  • Fig. 48 Transthoracic Needle Aspiration Market, Volume 2021 - 2033 (000')
  • Fig. 49 Traditional Bronchoscopy Market 2021 - 2033 (USD Million)
  • Fig. 50 Traditional Bronchoscopy Market, Volume 2021 - 2033 (000')
  • Fig. 51 Surgical Biopsy Market 2021 - 2033 (USD Million)
  • Fig. 52 Surgical Biopsy Market Volume 2021 - 2033 (000')
  • Fig. 53 Electromagnetic Navigation Bronchoscopy (ENB) Market 2021 - 2033 (USD Million)
  • Fig. 54 Electromagnetic Navigation Bronchoscopy (ENB) Market, Volume 2021 - 2033 (000')
  • Fig. 55 Robotic-Assisted Bronchoscopy Market 2021 - 2033 (USD Million)
  • Fig. 56 Robotic-Assisted Bronchoscopy Market, Volume 2021 - 2033 (000')
  • Fig. 57 US Endobronchial Ultrasound Biopsy (EBUS) CPT Codes Market: Segment Dashboard
  • Fig. 58 US Endobronchial Ultrasound Biopsy (EBUS) Market By CPT Codes Market Share Analysis, 2025 & 2033
  • Fig. 59 31652 Market, 2021-2033 (USD Million)
  • Fig. 60 31652 Market, Volume 2021 - 2033 (000')
  • Fig. 61 31653 Market 2021-2033 (USD Million)
  • Fig. 62 31653 Market, Volume 2021 - 2033 (000')
  • Fig. 63 31654 Market 2021-2033 (USD Million)
  • Fig. 64 31654 Market, Volume 2021 - 2033 (000')
  • Fig. 65 US Endobronchial Ultrasound Biopsy (EBUS) Site Market: Segment Dashboard
  • Fig. 66 US Endobronchial Ultrasound Biopsy (EBUS) Market By Site: Market Share Analysis, 2025 & 2033
  • Fig. 67 Academic Medical Centers Market, 2021 - 2033 (USD Million)
  • Fig. 68 Academic Medical Centers Market, Volume 2021 - 2033 (000')
  • Fig. 69 Community Hospitals Market 2021 - 2033 (USD Million)
  • Fig. 70 Community Hospitals Market, Volume 2021 - 2033 (000')
  • Fig. 71 Ambulatory Surgical Centers (ASCs) Market 2021 - 2033 (USD Million)
  • Fig. 72 Ambulatory Surgical Centers (ASCs) Market, Volume 2021 - 2033 (000')
  • Fig. 73 US Endobronchial Ultrasound Biopsy (EBUS) Procedure vs Site Market: Segment Dashboard
  • Fig. 74 US Endobronchial Ultrasound Biopsy (EBUS) Market By Procedure vs Site : Market Share Analysis, 2025 & 2033
  • Fig. 75 Standalone EBUS Lymph Node Biopsy Procedures Market, 2021 - 2033 (USD Million)
  • Fig. 76 Standalone EBUS Lymph Node Biopsy Procedures Market, Volume 2021 - 2033 (000')
  • Fig. 77 Academic Medical Centers Market, 2021 - 2033 (USD Million)
  • Fig. 78 Academic Medical Centers Market, Volume 2021 - 2033 (000')
  • Fig. 79 Community Hospitals Market 2021 - 2033 (USD Million)
  • Fig. 80 Community Hospitals Market, Volume 2021 - 2033 (000')
  • Fig. 81 Ambulatory Surgical Centers (ASCs) Market 2021 - 2033 (USD Million)
  • Fig. 82 Ambulatory Surgical Centers (ASCs) Market, Volume 2021 - 2033 (000')
  • Fig. 83 Combined Procedures Market 2021-2033 (USD Million)
  • Fig. 84 Combined Procedures Market, Volume 2021 - 2033 (000')
  • Fig. 85 Academic Medical Centers Market, 2021 - 2033 (USD Million)
  • Fig. 86 Academic Medical Centers Market, Volume 2021 - 2033 (000')
  • Fig. 87 Community Hospitals Market 2021 - 2033 (USD Million)
  • Fig. 88 Community Hospitals Market, Volume 2021 - 2033 (000')
  • Fig. 89 Ambulatory Surgical Centers (ASCs) Market 2021 - 2033 (USD Million)
  • Fig. 90 Ambulatory Surgical Centers (ASCs) Market, Volume 2021 - 2033 (000')
  • Fig. 91 Company Categorization
  • Fig. 92 Company Market Share Analysis, 2025 (%) - Overall Product Level
  • Fig. 93 Company Market Share Analysis For EBUS Scopes, 2025 (%)
  • Fig. 94 Company Market Position Analysis, 2025
  • Fig. 95 Strategic Framework